DermTech Cash Conversion Cycle 2011-2026 | DMTK

Annual Cash Conversion Cycle DermTech

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
66.7	60.5	15.3	2.14	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
66.7	2.14	36.2

Quarterly Cash Conversion Cycle DermTech

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
69	74.2	94	-	141	115	67.3	-	17.3	-9.59	-26.6	-	15.8	67.2	-52.1	-	-74.5	-108	-34.3	-	24.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
141	-108	23.8

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Trinity Biotech plc TRIB	136	$ 0.65	-1.84 %	$ 61.9 M	Irlanda
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Agilent Technologies A	111	$ 115.55	1.0 %	$ 35.1 B	USA
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
Aspira Women's Health AWH	1.01 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
Co-Diagnostics CODX	-2.46 K	$ 1.67	-2.34 %	$ 2.22 M	USA
Castle Biosciences CSTL	45.9	$ 24.46	3.25 %	$ 679 M	USA
CareDx, Inc CDNA	51.5	$ 21.23	5.83 %	$ 1.13 B	USA
Lantheus Holdings LNTH	97.3	$ 84.33	1.82 %	$ 5.69 B	USA
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	42.5	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	42.4	$ 16.31	1.75 %	$ 493 M	USA
Medpace Holdings MEDP	50.4	$ 410.54	4.35 %	$ 11.8 B	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	65	$ 169.8	1.23 %	$ 8.42 B	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Guardant Health GH	79.6	$ 88.91	1.18 %	$ 11.1 B	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
Interpace Biosciences IDXG	62.9	$ 1.98	-2.37 %	$ 8.76 M	USA
Illumina ILMN	142	$ 127.88	1.95 %	$ 20.3 B	USA
National Research Corporation NRC	29.4	$ 17.23	-0.12 %	$ 386 M	USA
Koninklijke Philips N.V. PHG	89	$ 27.47	-0.58 %	$ 20 B	Niderland
Personalis PSNL	-11.5	$ 6.1	3.39 %	$ 361 M	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Biomerica BMRA	172	$ 2.14	-0.47 %	$ 4.92 M	USA
ICON Public Limited Company ICLR	62	$ 102.17	-3.92 %	$ 8.43 B	Irlanda
Laboratory Corporation of America Holdings LH	40.3	$ 263.8	-0.43 %	$ 21.9 B	USA
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Thermo Fisher Scientific TMO	70	$ 469.71	0.64 %	$ 177 B	USA
NeoGenomics NEO	82.4	$ 8.29	4.8 %	$ 1.06 B	USA
Neogen Corporation NEOG	150	$ 9.54	2.03 %	$ 2.07 B	USA
Twist Bioscience Corporation TWST	83.6	$ 60.94	3.55 %	$ 3.64 B	USA
Myriad Genetics MYGN	49.3	$ 4.78	-0.21 %	$ 443 M	USA
Natera NTRA	81.5	$ 203.75	1.3 %	$ 20.1 B	USA
Quest Diagnostics Incorporated DGX	39.5	$ 196.27	-1.66 %	$ 21.8 B	USA
Invitae Corporation NVTA	299	-	-	$ 21.2 M	USA
Organovo Holdings ONVO	-82.8 K	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	4.66	-	-16.95 %	$ 1.54 M	USA
Waters Corporation WAT	731	$ 309.87	-0.43 %	$ 18.5 B	USA